Spermosens (Germany) Performance

9R5 Stock   0  0.0002  16.67%   
Spermosens holds a performance score of 15 on a scale of zero to a hundred. The entity has a beta of 5.02, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Spermosens will likely underperform. Use Spermosens AB market risk adjusted performance, coefficient of variation, information ratio, as well as the relationship between the mean deviation and standard deviation , to analyze future returns on Spermosens AB.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Spermosens AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Spermosens reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Spermosens and Sapyen sign Memorandum of Understanding to advance male fertility diagnostics - Finansavisen
01/16/2026
  

Spermosens Relative Risk vs. Return Landscape

If you would invest  0.02  in Spermosens AB on November 21, 2025 and sell it today you would earn a total of  0.12  from holding Spermosens AB or generate 600.0% return on investment over 90 days. Spermosens AB is currently producing 26.8553% returns and takes up 134.1616% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Spermosens, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Spermosens is expected to generate 179.89 times more return on investment than the market. However, the company is 179.89 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of risk.

Spermosens Target Price Odds to finish over Current Price

The tendency of Spermosens Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0 90 days 0 
about 1.13
Based on a normal probability distribution, the odds of Spermosens to move above the current price in 90 days from now is about 1.13 (This Spermosens AB probability density function shows the probability of Spermosens Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the stock has the beta coefficient of 5.02 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Spermosens will likely underperform. In addition to that Spermosens AB has an alpha of 27.1778, implying that it can generate a 27.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Spermosens Price Density   
       Price  

Predictive Modules for Spermosens

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spermosens AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.00050.07
Details
Intrinsic
Valuation
LowRealHigh
0.00050.07
Details
Naive
Forecast
LowNextHigh
0.0000280134.16
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.006900.01
Details

Spermosens Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Spermosens is not an exception. The market had few large corrections towards the Spermosens' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Spermosens AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Spermosens within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
27.18
β
Beta against Dow Jones5.02
σ
Overall volatility
0.0004
Ir
Information ratio 0.20

Spermosens Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spermosens for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spermosens AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Spermosens AB is way too risky over 90 days horizon
Spermosens AB has some characteristics of a very speculative penny stock
Spermosens AB appears to be risky and price may revert if volatility continues
Spermosens AB has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (10.2 M) with profit before overhead, payroll, taxes, and interest of 0.
Spermosens generates negative cash flow from operations

Spermosens Fundamentals Growth

Spermosens Stock prices reflect investors' perceptions of the future prospects and financial health of Spermosens, and Spermosens fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spermosens Stock performance.

About Spermosens Performance

By analyzing Spermosens' fundamental ratios, stakeholders can gain valuable insights into Spermosens' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spermosens has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spermosens has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spermosens is entity of Germany. It is traded as Stock on F exchange.

Things to note about Spermosens AB performance evaluation

Checking the ongoing alerts about Spermosens for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spermosens AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Spermosens AB is way too risky over 90 days horizon
Spermosens AB has some characteristics of a very speculative penny stock
Spermosens AB appears to be risky and price may revert if volatility continues
Spermosens AB has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (10.2 M) with profit before overhead, payroll, taxes, and interest of 0.
Spermosens generates negative cash flow from operations
Evaluating Spermosens' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Spermosens' stock performance include:
  • Analyzing Spermosens' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spermosens' stock is overvalued or undervalued compared to its peers.
  • Examining Spermosens' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Spermosens' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spermosens' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Spermosens' stock. These opinions can provide insight into Spermosens' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Spermosens' stock performance is not an exact science, and many factors can impact Spermosens' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Spermosens Stock analysis

When running Spermosens' price analysis, check to measure Spermosens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spermosens is operating at the current time. Most of Spermosens' value examination focuses on studying past and present price action to predict the probability of Spermosens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spermosens' price. Additionally, you may evaluate how the addition of Spermosens to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamental Analysis
View fundamental data based on most recent published financial statements
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges